Irritable Bowel Syndrome (IBS)
What is Irritable Bowel Syndrome?
According to the American College of Gastroenterology (ACG) IBS is a disorder of gut-brain interaction. Patients with Irritable Bowel Syndrome (IBS) suffer from changes in bowel habits such as constipation or diarrhea, and abdominal pain along with other symptoms including gas, bloating, and rectal urgency with diarrhea.
IBS may also be associated with non-intestinal symptoms, such as muscle aches, fatigue, headaches, back pain, and sometimes urinary symptoms including urinary urgency, or urinary hesitation.
IBS AFFECTS APPROXIMATELY 1 PERSON IN 5 WORLDWIDE
- Up to 5%of the US population (17 Million people) in the USA suffer from IBS.
- While more common in women: IBS affects both men and women.
NOT A TRIVIAL ILLNESS
- IBS deeply affects quality of life and the ability of people to function in their daily life.
- IBS has direct medical costs of several billion dollars each year in the USA alone.
Types of IBS
- IBS-C: IBS with constipation
- IBS-D: IBS with diarrhea
- IBS-Mixed: IBS with constipation and diarrhea
FOOD AND IBS
- 70-80% of IBS sufferers say food exacerbates or triggers their symptoms.
- Most sufferers cannot identify their offending foods. inFoods® IBS was developed to identify foods that triggers IBS symptoms.
- inFoods® IBS was clinically studied at the nation’s leading medical centers (Mayo Clinic, Harvard, University of Michigan, University of Texas Medical Center) with actual IBS Patients. When IBS patients in the study stopped eating foods identified by inFoods® IBS, the majority experienced significant improvement in their IBS symptoms including pain, bloating and bowel movement urgency.
inFoods® IBS is a laboratory developed test (LDT) powered by Ethos Laboratories , a CLIA and CAP-accredited high-complexity lab. inFoods® IBS has not been approved or cleared by the FDA.